kabutan

SANTEN PHARMACEUTICAL CO.,LTD.(4536) Summary

4536
TSE Prime
SANTEN PHARMACEUTICAL CO.,LTD.
1,650.5
JPY
+3.0
(+0.18%)
Apr 28, 3:30 pm JST
10.36
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
15.6
PBR
1.87
Yield
2.30%
Margin Trading Ratio
18.85
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
1,651.0 JPY 10.36 USD
Previous Close Apr 27
1,647.5 JPY 10.33 USD
High Apr 28, 9:00 am
1,652.0 JPY 10.37 USD
Low Apr 28, 9:27 am
1,631.0 JPY 10.23 USD
Volume
656,000
Trading Value
1.08B JPY 6.78M USD
VWAP
1646.63 JPY 10.34 USD
Minimum Trading Value
165,050 JPY 1,036 USD
Market Cap
0.53T JPY 3.35B USD
Number of Trades
1,391
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
High
1-Year Average
2,454
1-Year High Aug 8, 2025
10,497
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 22,400 59,300 2.65
Apr 17, 2026 27,300 55,900 2.05
Apr 10, 2026 36,000 51,400 1.43
Apr 3, 2026 29,400 51,900 1.77
Mar 27, 2026 22,500 50,000 2.22
Company Profile
SANTEN PHARMACEUTICAL CO., LTD. is a leading manufacturer of ophthalmic pharmaceuticals. Its flagship product is the over-the-counter eye drop brand "Sante". The company is strengthening its global expansion.
Sector
Pharmaceuticals
SANTEN PHARMACEUTICAL CO., LTD. primarily focuses on prescription pharmaceuticals, while also engaging in the research, development, manufacturing, and sales of over-the-counter drugs and medical devices. The company specializes in ophthalmology products. It operates globally, with a presence in Japan, China, Asia, Europe, the Middle East, Africa, North America, and other regions worldwide, forming a global corporate group. The overseas sales ratio accounts for approximately 40% of total revenue. The group consists of SANTEN PHARMACEUTICAL CO., LTD., 34 consolidated subsidiaries, and 2 equity-method affiliates. With numerous subsidiaries across the globe, the group implements business strategies tailored to the market characteristics of each region.